Reduced platelet serotonin content and release in familial hypercholesterolaemia

被引:17
作者
Smith, CCT
Betteridge, DJ
机构
[1] Univ. College London Medical School, Sir Jules Thorn Institute, Middlesex Hospital, London W1N 8AA, Mortimer Street
基金
英国惠康基金;
关键词
platelets; serotonin; release; familial hypercholesterolaemia; ESSENTIAL-HYPERTENSION; BLOOD-PLATELETS; INTRAPLATELET SEROTONIN; BETA-THROMBOGLOBULIN; PLASMA ADRENALINE; CORONARY-ARTERY; CHOLESTEROL; CATECHOLAMINES; 5-HYDROXYTRYPTAMINE; METABOLISM;
D O I
10.1016/S0021-9150(96)06048-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma and platelet serotonin (5-HT) concentrations, and resting and collagen-induced 5-HT release in platelet-rich plasma were studied in normal and familial hypercholesterolaemic (FH) subjects. Platelet 5-HT concentrations were significantly reduced (-37%, P < 0.01) in FH patients whilst mean plasma concentrations, although increased, were not significantly different from those in normal subjects. Platelet 5-HT correlated negatively with plasma cholesterol when the data for normal subjects and FH patients were combined (r = -0.48, P = 0.005). It also correlated negatively with low-density lipoprotein (LDL) (FH data, r = -0.59, P = 0.03; normal and FH data, r = -0.49, P = 0.004) but positively with high-density lipoprotein (HDL) (FH, r = 0.79, P = 0.001; normal and FH, r = 0.37, P = 0.03). Collagen (5-160 mu g/ml) stimulated platelet 5-HT release occurred in a concentration-dependent manner. In FH patients stimulated 5-HT release was reduced (10 mu g/ml collagen, -40%, P < 0.05) and accompanied by increased collagen EC50 values (P < 0.02). Resting 5-HT release was increased substantially in FH patients but not significantly. Our data provide evidence for a relationship between circulating cholesterol and platelet serotonergic mechanisms. It is proposed that abnormalities relating to platelet-plasma 5-HT dynamics, perhaps due to enhanced platelet activity or decreased platelet uptake, may contribute to the cardiovascular complications in FH. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:87 / 92
页数:6
相关论文
共 43 条
  • [1] ABRAMS WB, 1969, CLIN PHARMACOL THER, V10, P702
  • [2] AN EXAMINATION OF SOME FACTORS WHICH INFLUENCE THE STABILITY OF IN-VITRO PLATELET RESPONSES
    ALARAYYID, NA
    GRAHAM, BR
    FERDOUS, AH
    BETTERIDGE, DJ
    PRICHARD, BNC
    SMITH, CCT
    [J]. PLATELETS, 1994, 5 (06) : 317 - 324
  • [3] INTRAPLATELET SEROTONIN IN PATIENTS WITH DIABETES-MELLITUS AND PERIPHERAL VASCULAR-DISEASE
    BARRADAS, MA
    GILL, DS
    FONSECA, VA
    MIKHAILIDIS, DP
    DANDONA, P
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1988, 18 (04) : 399 - 404
  • [4] BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891
  • [5] PLASMA-FREE AND INTRAPLATELET SEROTONIN IN PATIENTS WITH RAYNAUD PHENOMENON
    BIONDI, ML
    MARASINI, B
    BIANCHI, E
    AGOSTONI, A
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1988, 19 (03) : 335 - 339
  • [6] UPTAKE, METABOLISM AND RELEASE OF H-3!-ADRENALINE BY HUMAN PLATELETS
    BORN, GVR
    SMITH, JB
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1970, 39 (04) : 765 - &
  • [7] PLATELET-FUNCTION IN HYPERLIPOPROTEINEMIA
    CARVALHO, AC
    COLMAN, RW
    LEES, RS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (08) : 434 - 438
  • [8] CAVIEZEL F, 1982, DIABETOLOGIA, V23, P19
  • [9] CHRISTENSEN NJ, 1974, DIABETES, V23, P1
  • [10] DAPRADA M, 1979, BRIT J PHARMACOL, V65, P653